Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Identifying and managing patients with hyperlipidemia.

A B Clark1, J M Holt

  • 1Department of Pharmacy Services, Veteran's Affairs Medical Center, Memphis, TN, USA.

The American Journal of Managed Care
|July 6, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The APOLLO trial: a proof-of-concept study for vitamin A nasal drops in COVID-19-related postinfectious olfactory dysfunction.

Chemical senses·2026
Same author

A randomised controlled trial of energetic activity for depression in young people (READY): a multi-site feasibility trial protocol.

Pilot and feasibility studies·2021
Same author

Modeling the effects of standardized ileal digestible isoleucine to lysine ratio on growth performance of nursery pigs<sup></sup>.

Translational animal science·2020
Same author

Modeling the effects of standardized ileal digestible valine to lysine ratio on growth performance of nursery pigs<sup></sup>.

Translational animal science·2020
Same author

Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT-ROC feasibility study.

BJS open·2020
Same author

Impact of stroke-associated pneumonia on mortality, length of hospitalization, and functional outcome.

Acta neurologica Scandinavica·2018

Lowering high lipid levels is crucial for preventing cardiovascular disease. Lifestyle changes and medication, guided by National Cholesterol Education Panel (NCEP) guidelines, effectively manage hyperlipidemia and reduce heart risks.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Public Health

Background:

  • Hyperlipidemia significantly contributes to cardiovascular disease morbidity and mortality in the U.S.
  • Clinical trials confirm the benefits of lipid level reduction in diverse patient populations.
  • The National Cholesterol Education Panel (NCEP) was established to create guidelines for lipid disorder management.

Purpose of the Study:

  • To outline the identification and treatment strategies for hyperlipidemia.
  • To emphasize the importance of lifestyle modifications and pharmacologic interventions.
  • To present the NCEP guidelines for managing lipid disorders.

Main Methods:

  • Evaluation for secondary causes of hyperlipidemia before treatment.
  • Identification of cardiovascular disease risk factors to set low-density lipoprotein (LDL) goals.

Related Experiment Videos

  • Implementation of NCEP's two-step dietary plan to reduce cholesterol and fat intake.
  • Incorporation of nonpharmacologic treatments: exercise, weight reduction, alcohol moderation, smoking cessation.
  • Consideration of pharmacologic therapy for patients unresponsive to lifestyle changes.
  • Review of principal lipid-lowering agents: bile acid sequestrants, nicotinic acid, HMG CoA reductase inhibitors, fibric acid derivatives.

    • Main Results:

    • Dietary changes are the cornerstone of hyperlipidemia treatment.
    • Pharmacoeconomic studies demonstrate that lipid-lowering therapy reduces medical interventions.
    • Estrogen, fish oil, and alcohol may also reduce heart disease risk.

    Conclusions:

    • Comprehensive management of hyperlipidemia involves lifestyle changes and, when necessary, pharmacologic therapy.
    • Adherence to NCEP guidelines is essential for effective lipid disorder management.
    • Effective hyperlipidemia treatment can decrease healthcare utilization and costs associated with cardiovascular disease.